December 2019

Volume 15 Number 11

In this issue the NOTION TRIAL looks at the cost-effectiveness of TAVI in patients at lower surgical risk; the final results of the REDUCE trial examining the optimal duration of DAPT in ACS patients treated with DES; a look at the impact of FFR in guiding CABG – the GRAFFITI trial; BIOFLOW-IV, studying the Orsiro sirolimus-eluting stent; and a study of multivessel PCIs in patients with acute myocardial infarction (AMI) and severe renal dysfunction.

Highlights from this issue

Geisler B, Jørgensen T, Thyregod H, Pietzsch J, Søndergaard L

December 6, 2019

DOI: 10.4244/EIJ-D-18-00847

Toth G, De Bruyne B, Kala P, Ribichini F, Casselman F, Ramos R, Piroth Z, Fournier S, Piccoli A, Van Mieghem C, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E

December 6, 2019

DOI: 10.4244/EIJ-D-19-00463

Saito S, Toelg R, Witzenbichler B, Haude M, Masotti M, Salmeron R, Witkowski A, Uematsu M, Takahashi A, Waksman R, Slagboom T

December 6, 2019

DOI: 10.4244/EIJ-D-18-01214

Editorial

Antiplatelet strategies for complex PCI

December 6, 2019 | 10.4244/EIJV15I11A174

Short DAPT duration after ACS – not for the faint of heart

Mihatov N, Yeh R

December 6, 2019 | 10.4244/EIJV15I11A175

Are all DES equal at 10-year follow-up?

Bär S, Windecker S, Räber L

December 6, 2019 | 10.4244/EIJV15I11A176

FFR for CABG: not ready for prime time

Gaudino M, Di Franco A, Taggart D

December 6, 2019 | 10.4244/EIJV15I11A177

Complete revascularisation in patients with acute myocardial infarction: is renal function the lock and patient selection the key?

Andò G, Vizzari G, Trio O

December 6, 2019 | 10.4244/EIJV15I11A178

Cost-effectiveness of TAVR in low-risk patients: do we have more than a NOTION?

Galper B, Baron S, Cohen D

December 6, 2019 | 10.4244/EIJV15I11A179

Perspectives

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019 | 10.4244/EIJV15I11A180

Interventions for valvular disease and heart failure

Clinical research

Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients at lower surgical risk: results from the NOTION trial

Geisler B, Jørgensen T, Thyregod H, Pietzsch J, Søndergaard L

December 6, 2019 | 10.4244/EIJ-D-18-00847

Clinical research

The changing landscape of aortic valve replacement in the USA

Gupta T, Kolte D, Khera S, Goel K, Villablanca P, Kalra A, Abbott J, Elmariah S, Fonarow G, Rihal C, Garcia M, Weisz G, Bhatt D

December 6, 2019 | 10.4244/EIJ-D-19-00381

Preclinical research

Preclinical evaluation of a transcatheter aortic valve replacement system for patients with rheumatic heart disease

Scherman J, Ofoegbu C, Myburgh A, Swanevelder J, van Breda B, Appa H, Human P, Williams D, Bezuidenhout D, Zilla P

December 6, 2019 | 10.4244/EIJ-D-18-01052

Clinical research

Transcatheter mitral valve replacement: factors associated with screening success and failure

Coisne A, Pontana F, Tchétché D, Richardson M, Longère B, Vahdat O, Berthoumieu P, Van Belle E, Rousse N, Lancellotti P, Montaigne D, Dumonteil N, Modine T

December 6, 2019 | 10.4244/EIJ-D-19-00444

Coronary interventions

Clinical research

Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)

De Luca G, Damen S, Camaro C, Benit E, Verdoia M, Rasoul S, Liew H, Polad J, Ahmad W, Zambahari R, Postma S, Kedhi E, Suryapranata H

December 6, 2019 | 10.4244/EIJ-D-19-00539

Clinical research

Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial

Toth G, De Bruyne B, Kala P, Ribichini F, Casselman F, Ramos R, Piroth Z, Fournier S, Piccoli A, Van Mieghem C, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E

December 6, 2019 | 10.4244/EIJ-D-19-00463

Clinical research

BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months

Saito S, Toelg R, Witzenbichler B, Haude M, Masotti M, Salmeron R, Witkowski A, Uematsu M, Takahashi A, Waksman R, Slagboom T

December 6, 2019 | 10.4244/EIJ-D-18-01214

Clinical research

Multivessel percutaneous coronary intervention in patients with acute myocardial infarction and severe renal dysfunction

Song P, Hahn J, Gwon H, Jeon K, Yu C, Rha S, Yoon C, Jeong M

December 6, 2019 | 10.4244/EIJ-D-19-00034

Short report

Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

Pareek M, Madsen M, Warnakula Olesen K, Okkels Jensen L, Christiansen E, Dalby Kristensen S, Flensted Lassen J, Thuesen L, Bøtker H, Maeng M

December 6, 2019 | 10.4244/EIJ-D-19-00503

Image – Interventional flashlight

Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention

Azzalini L, Bellini B, Montorfano M, Carlino M

December 6, 2019 | 10.4244/EIJ-D-19-00175

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke